对于前100名儿科药物的无质选择
Kelly L Matson1, Clara L Forbes2, Katelyn E Burton3
1Department of Pharmacy Practice (KLM), University of Rhode Island, Kingston, RI.
概括
许多儿科药物含有质,对患有乳症的儿童构成风险. 这项研究评估了顶级儿科药物的无质状态,发现了显著的变化和不完整的制造商数据.
科学领域:
- 儿科药理学 儿科药理学
- 胃肠病学 胃肠病学
- 食品科学 食品科学 食品科学
背景情况:
- 越来越多的人被诊断为患有乳病和对质敏感,特别是在儿童中.
- 确定药物质含量的现有资源往往不完整,专注于成年人.
- 对于特定于儿科药物的精确质信息有着极大的需求.
研究的目的:
- 评估100种最常使用的儿科药物的无质状态.
- 鉴定因药物质含量而导致腹腔疾病的儿科患者的潜在风险.
- 为了突出有关儿科药物质水平的当前信息的空白.
主要方法:
- 通过使用Optum Clinformatics Data Mart数据库,确定了前100种儿科药物.
- 获得了每个已识别的药物的国家药物代码 (NDC) 和制造商信息.
- 直接联系药品制造商,询问质含量和交叉污染协议.
主要成果:
- 对689个NDC的分析显示,50.2%的儿科药物被记录为无质.
- 很大一部分药物无法确认无质状态或交叉污染 (22.6%确认无质,但交叉污染未知;25.7%无法确认无质状态).
- 只有1.5%的评估药物被证实含有质,但数据可能随着制造业的变化而演变.
结论:
- 儿科药物表现出不同的质含量,与成人配方不同.
- 显而易见的是,关于儿科药物的质含量,缺乏全面和可访问的信息.
- 为儿童药物质含量开发专门的资源对于支持患有乳症的儿童至关重要.
相关概念视频
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Prescription, Nonprescription and Orphan Drugs
857
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
857
Allergic Drug Reactions
1.0K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.0K
Inborn Errors of Metabolism
249
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
249
Drug Delivery: Parenteral Route
898
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
898
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
484
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
484


